American Association for Cancer Research
10559965epi140130-sup-fig_1.pdf (40.48 kB)

Supplementary Figure 1 from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype

Download (40.48 kB)
journal contribution
posted on 2023-03-31, 13:23 authored by Mandi Yu, Eric J. Feuer, Kathleen A. Cronin, Neil E. Caporaso

PDF - 40K, Observed and imputed incidence rates by histologic subtype and gender, all malignant cancer cases, SEER 9, 1975-2010.



Background: Over the past several decades, advances in lung cancer research and practice have led to refinements of histologic diagnosis of lung cancer. The differential use and subsequent alterations of nonspecific morphology codes, however, may have caused artifactual fluctuations in the incidence rates for histologic subtypes, thus biasing temporal trends.Methods: We developed a multiple imputation (MI) method to correct lung cancer incidence for nonspecific histology using data from the Surveillance, Epidemiology, and End Results Program during 1975 to 2010.Results: For adenocarcinoma in men and squamous in both genders, the change to an increasing trend around 2005, after more than 10 years of decreasing incidence, is apparently an artifact of the changes in histopathology practice and coding system. After imputation, the rates remained decreasing for adenocarcinoma and squamous in men, and became constant for squamous in women.Conclusions: As molecular features of distinct histologies are increasingly identified by new technologies, accurate histologic distinctions are becoming increasingly relevant to more effective “targeted” therapies, and therefore, are important to track in patients. However, without incorporating the coding changes, the incidence trends estimated for histologic subtypes could be misleading.Impact: The MI approach provides a valuable tool for bridging the different histology definitions, thus permitting meaningful inferences about the long-term trends of lung cancer by histologic subtype. Cancer Epidemiol Biomarkers Prev; 23(8); 1546–58. ©2014 AACR.

Usage metrics

    Cancer Epidemiology, Biomarkers & Prevention



    Ref. manager